Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
38.42    -0.88 (-2.24%)
Bid:
38.28
Ask:
38.42
Spread: 0.14 (0.366%)
Market Cap: £389.08m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Form 8.5 (EPT/RI)-Aston Martin LagondaGlblHldisplc

18 Jul 2019 09:56

RNS Number : 9762F
JPMorgan Securities Plc
18 July 2019
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Aston Martin Lagonda Global Holdings plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Corporate Broker to Aston Martin Lagonda Global Holdings plc

(d) Date dealing undertaken:

17 July 2019

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

(GBP)

Lowest price per unit paid/received

(GBP)

Ordinary Share

 

Purchase

 

Sale

116,915

 

72,515

10.1869

 

10.2199

9.7530

 

9.7707

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary Share

 

Equity Swap

Long

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,449

1,391

11,692

650

1,298

9

525

327

15

21

14

1,743

79

14,769

1,688

732

500

487

5

12

127

 

103

9

2

5,540

51

1

37

229

40

4,927

48

3,511

2,267

573

520

149

2,277

535

745

1,669

1,267

358

1,259

520

192

1,814

9,493

2,741

5,226

2,142

7,122

40

10,929

7

10,136

523

1,773

1,985

104

373

334

458

9.7800 GBP

9.8215 GBP

9.8495 GBP

9.8560 GBP

9.8894 GBP

9.9276 GBP

9.9299 GBP

9.9304 GBP

9.9492 GBP

9.9548 GBP

9.9639 GBP

10.0086 GBP

10.0168 GBP

10.0563 GBP

10.0714 GBP

10.0900 GBP

10.1419 GBP

10.1994 GBP

10.2141 GBP

10.2144 GBP

10.2145 GBP

 

9.7540 GBP

9.7664 GBP

9.7743 GBP

9.7800 GBP

9.7804 GBP

9.7943 GBP

9.8052 GBP

9.8056 GBP

9.8065 GBP

9.8079 GBP

9.8098 GBP

9.8105 GBP

9.8113 GBP

9.8134 GBP

9.8161 GBP

9.8168 GBP

9.8183 GBP

9.8222 GBP

9.8251 GBP

9.8335 GBP

9.8527 GBP

9.8553 GBP

9.8560 GBP

9.8602 GBP

9.8621 GBP

9.8641 GBP

9.8654 GBP

9.8658 GBP

9.8961 GBP

9.9030 GBP

9.9099 GBP

9.9567 GBP

9.9607 GBP

10.0203 GBP

10.0302 GBP

10.0600 GBP

10.0807 GBP

10.0928 GBP

10.1251 GBP

10.1253 GBP

10.1870 GBP

10.1953 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

18 July 2019

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERGIGDRXUBBGCI
Date   Source Headline
9th Jun 202611:32 amRNSDirector/PDMR Shareholding
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.